Marker Therapeutics Inc (MRKR)

[Rkmatters]

No disrespect, but your comparison you suggested this board reviews is irrelevant. Five years ago they did not have the exclusive licensing deals with Mayo. You can't value them at patents they didn't secure before last year. (Well you can, but that doesn't mean it's a fair comparison). Those Mayo trials are the ones that are being moving forward, and those are what the company received funding to do and should be valued at. Whether it is today or tomorrow or when study news comes in, the value with commensurate with what the market is willing to pay. Today shares are being offered for less. But sometimes shareholders are spooked by filings they don't understand or post that talk about stock splits. Others recognize stock prices fluctuate and fear talking. If this stock goes back to test lows, I've no doubts that many of us here will pick up those shares only to then eventually sell out our higher cost shares when the market understands the opportunity. I have no doubts this will see $1 again, including for split adjustments as the stages of the trial move forward. Time will eventually pass, and it will happen. IMHO.